查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418356

瑞德西韋市場報告：2030 年趨勢、預測與競爭分析

Remdesivir Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

瑞德西韋趨勢與預測

預計 2024 年至 2030 年，全球瑞德西韋市場將以 7.0% 的複合年成長率成長。該市場的主要促進因素是病毒感染病例數量的增加、農村地區不衛生習慣的增加以及對病毒感染預防的需求不斷增加。全球瑞德西韋市場未來性廣闊，醫院藥局、零售藥局和線上藥局市場充滿機會。

瑞德西韋市場洞察

Lucintel預測，由於100MG能夠抑制SARS-COV-2病毒的複製，因此在預測期內仍將是最大的細分市場。

由於僅憑處方箋配藥，醫院藥房將繼續成為該市場最大的部分。

由於 COVID-19 的高流行，預計北美在預測期內仍將是最大的地區。

常問問題

Q1.市場成長預測如何？

A1. 2024年至2030年，全球瑞德西韋市場預計複合年成長率為7.0%。

Q2.影響市場成長的主要促進因素有哪些？

A2. 該市場的主要促進因素是病毒感染病例數量的增加、農村地區不衛生習慣的增加以及對病毒感染預防的需求不斷成長。

Q3.市場的主要細分市場有哪些？

A3. 瑞德西韋市場未來性廣闊，醫院藥局、零售藥局、網路藥局市場都有機會。

Q4.市場上主要企業有哪些？

A4.瑞德西韋涉及的主要企業如下。

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Q5.未來最大的細分市場是什麼？

A5.Lucintel 預計 100MG 在預測期內仍將是最大的細分市場，因為它抑制 SARS-COV-2 病毒的複製。

Q6. 未來五年預計哪個地區將成為最大的市場？

A6. 由於 COVID-19 的高流行，北美在預測期內仍將是最大的地區。

Q7. 可以客製化報告嗎？

A7. 是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球瑞德西韋市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球瑞德西韋市場趨勢（2018-2023）與預測（2024-2030）
  • 全球瑞德西韋市場劑量
    • 2.5MG
    • 5MG
    • 100MG
    • 200MG
  • 按型態
    • 凍乾粉
    • 濃縮液
  • 按用途
    • 伊波拉
    • SARS-COV
    • MERS-COV
  • 按分銷管道
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球瑞德西韋市場區域分佈
  • 瑞德西韋北美市場
  • 歐洲瑞德西韋市場
  • 亞太地區瑞德西韋市場
  • 其他地區瑞德西韋市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球瑞德西韋市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球瑞德西韋市場產能
    • 全球瑞德西韋市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy's Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private
簡介目錄

Remdesivir Trends and Forecast

The future of the global remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.

A more than 150-page report is developed to help in your business decisions.

Remdesivir by Segment

The study includes a forecast for the global remdesivir by dosage, form, application, distribution channel , and region.

Remdesivir Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

  • 2.5MG
  • 5MG
  • 100MG
  • 200MG

Remdesivir Market by Form [Shipment Analysis by Value from 2018 to 2030]:

  • Lyophilized Powder
  • Concentrated Solution

Remdesivir Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Ebola
  • SARS-Cov
  • MERS-Cov

Remdesivir Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Remdesivir Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Remdesivir Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies remdesivir companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the remdesivir companies profiled in this report include-

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Remdesivir Market Insights

Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.

Within this market, hospital pharmacy will remain the largest segment due to prescription-only medication.

North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.

Features of the Global Remdesivir Market

Market Size Estimates: Remdesivir market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Remdesivir market size by various segments, such as by dosage, form, application, distribution channel , and region in terms of value ($B).

Regional Analysis: Remdesivir market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, form, application, distribution channel , and regions for the remdesivir market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the remdesivir market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for remdesivir market?

Answer: The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the remdesivir market?

Answer: The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.

Q3. What are the major segments for remdesivir market?

Answer: The future of the remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q4. Who are the key remdesivir market companies?

Answer: Some of the key remdesivir companies are as follows.

  • Jubilant Life Sciences
  • Eva Pharma
  • Pfizer
  • Dr. Reddy'S Laboratories
  • Viatris Pharmaceuticals
  • Sun Pharmaceuticals Industries
  • Gilead Sciences India Private

Q5. Which remdesivir market segment will be the largest in future?

Answer: Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.

Q6. In remdesivir market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the high prevalence of COVID-19.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the remdesivir market by dosage (2.5MG, 5MG, 100MG, and 200MG), form (lyophilized powder and concentrated solution), application (ebola, SARS-cov, and MERS-cov), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Remdesivir Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Remdesivir Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Remdesivir Market by Dosage
    • 3.3.1: 2.5MG
    • 3.3.2: 5MG
    • 3.3.3: 100MG
    • 3.3.4: 200MG
  • 3.4: Global Remdesivir Market by Form
    • 3.4.1: Lyophilized Powder
    • 3.4.2: Concentrated Solution
  • 3.5: Global Remdesivir Market by Application
    • 3.5.1: Ebola
    • 3.5.2: SARS-COV
    • 3.5.3: MERS-COV
  • 3.6: Global Remdesivir Market by Distribution Channel
    • 3.6.1: Hospital Pharmacy
    • 3.6.2: Retail Pharmacy
    • 3.6.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Remdesivir Market by Region
  • 4.2: North American Remdesivir Market
    • 4.2.2: North American Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.3: European Remdesivir Market
    • 4.3.1: European Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.3.2: European Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.4: APAC Remdesivir Market
    • 4.4.1: APAC Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.4.2: APAC Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
  • 4.5: ROW Remdesivir Market
    • 4.5.1: ROW Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
    • 4.5.2: ROW Remdesivir Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Remdesivir Market by Dosage
    • 6.1.2: Growth Opportunities for the Global Remdesivir Market by Form
    • 6.1.3: Growth Opportunities for the Global Remdesivir Market by Application
    • 6.1.4: Growth Opportunities for the Global Remdesivir Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Remdesivir Market by Region
  • 6.2: Emerging Trends in the Global Remdesivir Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Remdesivir Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Remdesivir Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Jubilant Life Sciences
  • 7.2: Eva Pharma
  • 7.3: Pfizer
  • 7.4: Dr. Reddy's Laboratories
  • 7.5: Viatris Pharmaceuticals
  • 7.6: Sun Pharmaceuticals Industries
  • 7.7: Gilead Sciences India Private